ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/06/20 | 1,927 | 1,988 | 1,927 | 1,967 | +42 | +2.2% | 719,200 |
2017/06/19 | 1,909 | 1,940 | 1,880 | 1,925 | +192 | +11.1% | 1,020,400 |
2017/06/16 | 1,740 | 1,752 | 1,726 | 1,733 | +1 | +0.1% | 306,700 |
2017/06/15 | 1,729 | 1,750 | 1,725 | 1,732 | +8 | +0.5% | 110,000 |
2017/06/14 | 1,742 | 1,753 | 1,724 | 1,724 | -17 | -1% | 101,500 |
2017/06/13 | 1,742 | 1,752 | 1,733 | 1,741 | +10 | +0.6% | 62,200 |
2017/06/12 | 1,748 | 1,750 | 1,726 | 1,731 | -17 | -1% | 67,900 |
2017/06/09 | 1,747 | 1,761 | 1,740 | 1,748 | +11 | +0.6% | 115,600 |
2017/06/08 | 1,728 | 1,752 | 1,719 | 1,737 | +14 | +0.8% | 101,800 |
2017/06/07 | 1,730 | 1,731 | 1,709 | 1,723 | +5 | +0.3% | 105,400 |
2017/06/06 | 1,755 | 1,762 | 1,715 | 1,718 | -34 | -1.9% | 77,500 |
2017/06/05 | 1,743 | 1,763 | 1,724 | 1,752 | +2 | +0.1% | 85,600 |
2017/06/02 | 1,733 | 1,755 | 1,718 | 1,750 | +23 | +1.3% | 90,300 |
2017/06/01 | 1,701 | 1,728 | 1,701 | 1,727 | +27 | +1.6% | 52,600 |
2017/05/31 | 1,700 | 1,712 | 1,690 | 1,700 | -13 | -0.8% | 67,900 |
2017/05/30 | 1,726 | 1,726 | 1,698 | 1,713 | -17 | -1% | 76,900 |
2017/05/29 | 1,740 | 1,747 | 1,727 | 1,730 | -12 | -0.7% | 33,100 |
2017/05/26 | 1,787 | 1,787 | 1,741 | 1,742 | -45 | -2.5% | 52,600 |
2017/05/25 | 1,773 | 1,790 | 1,765 | 1,787 | +12 | +0.7% | 52,500 |
2017/05/24 | 1,770 | 1,778 | 1,766 | 1,775 | +13 | +0.7% | 48,000 |
2017/05/23 | 1,754 | 1,765 | 1,754 | 1,762 | +6 | +0.3% | 53,900 |
2017/05/22 | 1,750 | 1,760 | 1,744 | 1,756 | -4 | -0.2% | 39,400 |
2017/05/19 | 1,759 | 1,764 | 1,741 | 1,760 | +1 | +0.1% | 51,200 |
2017/05/18 | 1,739 | 1,759 | 1,733 | 1,759 | -7 | -0.4% | 70,400 |
2017/05/17 | 1,764 | 1,771 | 1,744 | 1,766 | -8 | -0.5% | 80,400 |
2017/05/16 | 1,731 | 1,776 | 1,719 | 1,774 | +65 | +3.8% | 128,500 |
2017/05/15 | 1,732 | 1,737 | 1,701 | 1,709 | -48 | -2.7% | 125,800 |
2017/05/12 | 1,757 | 1,766 | 1,740 | 1,757 | -16 | -0.9% | 59,400 |
2017/05/11 | 1,779 | 1,779 | 1,760 | 1,773 | -1 | -0.1% | 67,200 |
2017/05/10 | 1,770 | 1,779 | 1,751 | 1,774 | -6 | -0.3% | 72,900 |
2017/05/09 | 1,757 | 1,780 | 1,751 | 1,780 | +29 | +1.7% | 94,300 |
2017/05/08 | 1,728 | 1,761 | 1,727 | 1,751 | +39 | +2.3% | 157,800 |
2017/05/02 | 1,696 | 1,715 | 1,692 | 1,712 | +22 | +1.3% | 90,800 |
2017/05/01 | 1,677 | 1,690 | 1,653 | 1,690 | +16 | +1% | 75,200 |
2017/04/28 | 1,700 | 1,706 | 1,673 | 1,674 | -17 | -1% | 96,700 |
2017/04/27 | 1,690 | 1,696 | 1,679 | 1,691 | -2 | -0.1% | 93,800 |
2017/04/26 | 1,703 | 1,703 | 1,681 | 1,693 | +6 | +0.4% | 53,600 |
2017/04/25 | 1,685 | 1,695 | 1,677 | 1,687 | +3 | +0.2% | 47,700 |
2017/04/24 | 1,681 | 1,691 | 1,677 | 1,684 | +22 | +1.3% | 58,600 |
2017/04/21 | 1,655 | 1,666 | 1,649 | 1,662 | +5 | +0.3% | 71,900 |
2017/04/20 | 1,641 | 1,665 | 1,631 | 1,657 | +13 | +0.8% | 123,200 |
2017/04/19 | 1,636 | 1,653 | 1,635 | 1,644 | -4 | -0.2% | 123,100 |
2017/04/18 | 1,660 | 1,663 | 1,646 | 1,648 | +1 | +0.1% | 50,500 |
2017/04/17 | 1,621 | 1,656 | 1,621 | 1,647 | +15 | +0.9% | 55,100 |
2017/04/14 | 1,653 | 1,655 | 1,629 | 1,632 | -31 | -1.9% | 54,300 |
2017/04/13 | 1,660 | 1,671 | 1,648 | 1,663 | -9 | -0.5% | 82,300 |
2017/04/12 | 1,680 | 1,682 | 1,667 | 1,672 | -18 | -1.1% | 55,300 |
2017/04/11 | 1,682 | 1,700 | 1,682 | 1,690 | -3 | -0.2% | 55,900 |
2017/04/10 | 1,715 | 1,715 | 1,690 | 1,693 | +1 | +0.1% | 45,200 |
2017/04/07 | 1,701 | 1,712 | 1,689 | 1,692 | -5 | -0.3% | 84,700 |
2001~
2050
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,300円 | +3.1% | -6.5% | 2.36% | 9.44倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,100円 | +21.7% | +999.9% | 0.00% | 12.17倍 | 4.16倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 313,500円 | +5.1% | -7.0% | 2.55% | 20.58倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 248,100円 | +4.1% | -3.1% | 2.34% | 21.56倍 | 1.88倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 151,600円 | -2.4% | -52.3% | 3.76% | 18.14倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム